Loading clinical trials...
Loading clinical trials...
Phase II, Randomized, Double Blinded, Placebo Controlled Superiority Trial of Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
Conditions
Interventions
Calcium Gluconate
Saline
Locations
1
United States
University of Michigan
Ann Arbor, Michigan, United States
Start Date
October 20, 2025
Primary Completion Date
July 1, 2026
Completion Date
August 1, 2026
Last Updated
October 29, 2025
NCT01731444
NCT06601582
NCT06428682
NCT02910115
NCT06219538
NCT06078501
Lead Sponsor
University of Michigan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions